In the BioHarmony Drug Report Database

"Preview" Icon

Erythromycin lactobionate

Erythrocin (erythromycin lactobionate) is a small molecule pharmaceutical. Erythromycin lactobionate was first approved as Erythrocin on 1982-01-01. It is used to treat acne vulgaris, bacterial eye infections, bacterial infections, campylobacter infections, and chancroid amongst others in the USA. It is known to target motilin receptor.

 

Trade Name

 

Erythrocin
 

Common Name

 

erythromycin lactobionate
 

ChEMBL ID

 

CHEMBL1200506
 

Indication

 

acne vulgaris, bacterial eye infections, bacterial infections, campylobacter infections, chancroid, chlamydia infections, erythrasma, gastroenteritis, gonorrhea, legionnaires' disease, mycoplasma infections, protozoan infections, staphylococcal infections, streptococcal infections, syphilis, urethritis, whooping cough
 

Drug Class

 

Antibiotics (Streptomyces strains)

Image (chem structure or protein)

Erythromycin lactobionate structure rendering